Polyacetylenes from Notopterygium incisum–New SelectivePartial Agonists of Peroxisome Proliferator-ActivatedReceptor-GammaSubmitted by Andreas Schinkovitz on Wed, 04/29/2015 - 19:52Titre Polyacetylenes from Notopterygium incisum–New Selective Partial Agonists ofPeroxisome Proliferator-Activated Receptor-GammaType depublication Article de revueAuteurAtanasov, Atanas G [1], Blunder, Martina [2], Fakhrudin, Nanang [3], Liu, Xin [4],Noha, Stefan M [5], Malainer, Clemens [6], Kramer, Matthias P [7], Cocic, Amina [8],Kunert, Olaf [9], Schinkovitz, Andreas [10], Heiss, Elke H [11], Schuster, Daniela[12], Dirsch, Verena M [13], Bauer, Rudolf [14]Auteursecondaire Wagner, Bridget [15]Editeur Public Library of ScienceType Article scientifique dans une revue à comité de lectureAnnée 2013Langue AnglaisDate Oct-04-2014Numéro 4Volume 8Section e61755Titre de larevue PLoS ONERésumé enanglaisPeroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator ofglucose and lipid metabolism and therefore an important pharmacological target tocombat metabolic diseases. Since the currently used full PPARγ agonists displayserious side effects, identification of novel ligands, particularly partial agonists, ishighly relevant. Searching for new active compounds, we investigated extracts of theunderground parts of Notopterygium incisum, a medicinal plant used in traditionalChinese medicine, and observed significant PPARγ activation using a PPARγ-drivenluciferase reporter model. Activity-guided fractionation of the dichloromethaneextract led to the isolation of six polyacetylenes, which displayed properties ofselective partial PPARγ agonists in the luciferase reporter model. Since PPARγactivation by this class of compounds has so far not been reported, we have chosenthe prototypical polyacetylene falcarindiol for further investigation. The effect offalcarindiol (10 µM) in the luciferase reporter model was blocked upon co-treatmentwith the PPARγ antagonist T0070907 (1 µM). Falcarindiol bound to the purifiedhuman PPARγ receptor with a Ki of 3.07 µM. In silico docking studies suggested abinding mode within the ligand binding site, where hydrogen bonds to Cys285 andGlu295 are predicted to be formed in addition to extensive hydrophobic interactions.Furthermore, falcarindiol further induced 3T3-L1 preadipocyte differentiation andenhanced the insulin-induced glucose uptake in differentiated 3T3-L1 adipocytesconfirming effectiveness in cell models with endogenous PPARγ expression. Inconclusion, we identified falcarindiol-type polyacetylenes as a novel class of naturalpartial PPARγ agonists, having potential to be further explored as pharmaceuticalleads or dietary supplements.URL de lanotice http://okina.univ-angers.fr/publications/ua10581 [16]DOI 10.1371/journal.pone.0061755 [17]Lien vers ledocument http://dx.plos.org/10.1371/journal.pone.0061755 [18]Titre abrégé PLoS ONELiens[1] http://okina.univ-angers.fr/publications?f[author]=17342[2] http://okina.univ-angers.fr/publications?f[author]=17349[3] http://okina.univ-angers.fr/publications?f[author]=17350[4] http://okina.univ-angers.fr/publications?f[author]=17347[5] http://okina.univ-angers.fr/publications?f[author]=17351[6] http://okina.univ-angers.fr/publications?f[author]=17352[7] http://okina.univ-angers.fr/publications?f[author]=18749[8] http://okina.univ-angers.fr/publications?f[author]=18750[9] http://okina.univ-angers.fr/publications?f[author]=17348[10] http://okina.univ-angers.fr/a.schinkov/publications[11] http://okina.univ-angers.fr/publications?f[author]=17335[12] http://okina.univ-angers.fr/publications?f[author]=17354[13] http://okina.univ-angers.fr/publications?f[author]=17341[14] http://okina.univ-angers.fr/publications?f[author]=17340[15] http://okina.univ-angers.fr/publications?f[author]=18751[16] http://okina.univ-angers.fr/publications/ua10581[17] http://dx.doi.org/10.1371/journal.pone.0061755[18] http://dx.plos.org/10.1371/journal.pone.0061755Publié sur Okina (http://okina.univ-angers.fr)